Detalles de la búsqueda
1.
Prognostic nutritional index after introduction of atezolizumab with bevacizumab predicts prognosis in advanced hepatocellular carcinoma: A multicenter study.
Oncology
; 2024 Jan 18.
Artículo
Inglés
| MEDLINE | ID: mdl-38237558
2.
Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation.
Hepatol Res
; 53(4): 289-300, 2023 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-36461885
3.
The neutrophil-to-lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.
Hepatol Res
; 53(6): 511-521, 2023 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-36723964
4.
Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy.
Hepatol Res
; 47(12): 1308-1316, 2017 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-28332272
5.
Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C.
Hepatol Res
; 44(12): 1208-1216, 2014 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-24372894
6.
Noninvasive evaluation of hepatic fibrosis in hepatitis C virus-infected patients using ethoxybenzyl-magnetic resonance imaging.
J Gastroenterol Hepatol
; 28(6): 1032-9, 2013 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-23432660
7.
Case-control study of the RFA therapeutic effect of newly developed 4D US and conventional 2D US.
J Med Ultrason (2001)
; 40(1): 39-46, 2013 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-27276923
8.
Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis.
Cancer Med
; 2023 Dec 22.
Artículo
Inglés
| MEDLINE | ID: mdl-38133557
9.
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus.
J Gastroenterol
; 58(12): 1211-1221, 2023 12.
Artículo
Inglés
| MEDLINE | ID: mdl-37831182
10.
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis.
J Gastroenterol
; 57(2): 120-132, 2022 02.
Artículo
Inglés
| MEDLINE | ID: mdl-35059853
11.
Efficacies of first and second tumor necrosis factor inhibitors in refractory ulcerative colitis patients in real-world practice.
Indian J Gastroenterol
; 39(6): 565-575, 2020 Dec.
Artículo
Inglés
| MEDLINE | ID: mdl-33106991
12.
Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection.
Hepatol Res
; 39(1): 21-30, 2009 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-18721155
13.
Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
Dig Liver Dis
; 51(7): 967-971, 2019 07.
Artículo
Inglés
| MEDLINE | ID: mdl-30872086
14.
TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy.
J Gastroenterol
; 54(4): 339-346, 2019 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-30382363
15.
Percutaneous Transhepatic Self-expanding Metallic Stent Placement for the Treatment of Malignant Afferent Loop Obstruction.
Intern Med
; 57(3): 333-337, 2018 Feb 01.
Artículo
Inglés
| MEDLINE | ID: mdl-29093418
16.
Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy.
Medicine (Baltimore)
; 96(32): e7800, 2017 Aug.
Artículo
Inglés
| MEDLINE | ID: mdl-28796080
17.
Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1.
J Gastroenterol
; 52(1): 94-103, 2017 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-27236547
18.
Influence of genes suppressing interferon effects in peripheral blood mononuclear cells during triple antiviral therapy for chronic hepatitis C.
PLoS One
; 10(2): e0118000, 2015.
Artículo
Inglés
| MEDLINE | ID: mdl-25706116
19.
Tonsillar tuberculosis associated with pulmonary and laryngeal foci.
Intern Med
; 41(8): 664-6, 2002 Aug.
Artículo
Inglés
| MEDLINE | ID: mdl-12211539
20.
Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma.
Cancer Manag Res
; 4: 423-9, 2012.
Artículo
Inglés
| MEDLINE | ID: mdl-23293537